Bladder Cancer - Results from #360

Predicting bladder cancer risk in patients with hematuria. A single-centre retrospective study. March 24, 2023

Effective-by-method for the preparation of folic acid coated TiO2 nanoparticles with high targeting potential for apoptosis induction against bladder cancer cells (T24). March 24, 2023

Anthropometric characteristics and relationship with non-muscle invasive bladder cancer in Greece: A case-control study. March 23, 2023

Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade. March 23, 2023

Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer. March 22, 2023

Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma. March 22, 2023

First-line Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer: Chimera or "Ne Plus Ultra"? March 22, 2023

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study. March 22, 2023

Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma. March 21, 2023

Perioperative outcomes of open versus robot-assisted radical cystectomy in octogenarians: a population based analysis. March 21, 2023

National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. March 21, 2023

Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer. March 20, 2023

Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy. March 20, 2023

Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer. March 17, 2023

Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary. March 17, 2023

Correlation of Clinician- and Patient-Reported Outcomes in the BC2001 Trial. March 16, 2023

Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy. March 16, 2023

En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis. March 15, 2023

Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure? March 15, 2023

Validating Protein Targets for Imaging of Bladder Cancer Metastases - Expert Commentary March 14, 2023

Page 19 of 476